KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInvested CapitalMarket Capitalization

AbCellera Biologics (ABCL) Return on Invested Capital: 2021-2023

Historic Return on Invested Capital for AbCellera Biologics (ABCL) over the last 1 years, with Dec 2023 value amounting to -0.16%.

  • AbCellera Biologics' Return on Invested Capital fell 28.00% to -0.16% in Q4 2023 from the same period last year, while for Dec 2023 it was -0.16%, marking a year-over-year decrease of 28.00%. This contributed to the annual value of -0.23% for FY2024, which is 6.00% down from last year.
  • As of Q4 2023, AbCellera Biologics' Return on Invested Capital stood at -0.16%, which was down 18.22% from -0.14% recorded in Q3 2023.
  • AbCellera Biologics' 5-year Return on Invested Capital high stood at 0.19% for Q3 2022, and its period low was -0.16% during Q4 2023.
  • In the last 3 years, AbCellera Biologics' Return on Invested Capital had a median value of 0.14% in 2021 and averaged 0.07%.
  • Data for AbCellera Biologics' Return on Invested Capital shows a maximum YoY plummeted of 32bps (in 2023) over the last 5 years.
  • Quarterly analysis of 3 years shows AbCellera Biologics' Return on Invested Capital stood at 0.14% in 2021, then decreased by 3bps to 0.11% in 2022, then fell by 28bps to -0.16% in 2023.
  • Its Return on Invested Capital was -0.16% in Q4 2023, compared to -0.14% in Q3 2023 and 0.11% in Q4 2022.